FDA Inspection 1014319 — Arizona Center for Reproductive Endocrinology & Infertility
The FDA completed an inspection of Arizona Center for Reproductive Endocrinology & Infertility on March 22, 2017 in Tucson, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 22, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Tucson, AZ (United States)